-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IBI-345 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IBI-345 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IBI-345 in Gastric Cancer Drug Details: IBI-345 is under development for...
-
Company Insights
Innovation and Patenting activity of KH Neochem Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of KH Neochem Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KH-631 in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KH-631 in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.KH-631 in Wet (Neovascular / Exudative) Macular Degeneration Drug...
-
Product Insights
NewAnal Fistula – Drugs In Development, 2024
Empower your strategies with our Anal Fistula  – Drugs In Development, 2024 report and make more profitable business decisions. An anal fistula is a small tunnel that develops under the skin that connects the anal canal in the colon to the skin of the buttocks. It is also called as fistula-in-ano. The Anal Fistula drugs in development market research report provide comprehensive information on the therapeutics under development for Anal Fistula , complete with analysis by stage of development, drug...
-
Product Insights
NewRadiation Injury – Drugs In Development, 2024
Empower your strategies with our Radiation Injury – Drugs In Development, 2024 report and make more profitable business decisions. Radiation injury is damage to tissues caused by exposure to ionizing radiation. Symptoms depend on whether radiation exposure involves the whole body or is limited to a small portion of the body. At high doses, whole-body exposure causes acute radiation illness, and partial-body exposure causes local radiation injury. The Radiation Injury drugs in development market research report provide comprehensive information on the...
-
Product Insights
NewGastrointestinal Fistula – Drugs In Development, 2024
Empower your strategies with our Gastrointestinal Fistula  – Drugs In Development, 2024 report and make more profitable business decisions. A gastrointestinal fistula is an abnormal opening in the intestines that allows the contents to leak to another part of the body. These are a consequence of perforations that communicate with adjacent organs or intestine (internal fistulas) or externally with the abdominal wall. The Gastrointestinal Fistula drugs in development market research report provide comprehensive information on the therapeutics under development for...
-
Product Insights
NewRadiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024
Empower your strategies with our Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Radiation toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of ionizing radiation over a very short period of time (usually a matter of minutes). The root cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGBB-167 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBB-167 in Colorectal Cancer Drug Details: BGBB-167 is under development for the treatment of advanced...